BioPharm News

Jul 16, 2018
By BioPharm International Editors
Teva Pharmaceuticals, Major Pharmaceuticals, and Solco Healthcare are voluntarily recalling their products containing valsartan because of the presence of N-nitrosodimethylamine.
Jul 12, 2018
By BioPharm International Editors
Catalent Biologics will adopt Berkeley Lights’ Beacon optofluidic platform for its cell-line development workflow.
Jul 12, 2018
By BioPharm International Editors
The agency is releasing six new draft guidances to provide a regulatory framework for handling gene therapies.
Jul 12, 2018
By BioPharm International Editors
CPhI Korea to feature zone for finished dosage formulation drug products.
Jul 11, 2018
By BioPharm International Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 11, 2018
By BioPharm International Editors
The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.
Jul 11, 2018
By BioPharm International Editors
Teva Pharmaceuticals USA will move its US headquarters to Parsippany-Troy Hills, NJ.
Jul 10, 2018
By BioPharm International Editors
Findings from a survey show that some companies have not yet taken the necessary steps to ensure the continuity of medicine supply in the European Union after the United Kingdom’s departure.
Jul 10, 2018
By BioPharm International Editors
The expansion at the company’s Gillingham, UK, site, worth EUR 9 million (approximately US$10.5 million), will improve the company’s distribution capabilities.
Jul 10, 2018
By BioPharm International Editors
Progressive Care’s DischargeRX program works with hospitals and patients to help improve patient medication adherence and minimize medication-related hospital readmissions.
native1_300x100
lorem ipsum